Medicare Enrolled
Dr. Brent Vanhoozen, M.D.
Critical Care Medicine · Roseville, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Vanhoozen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vanhoozen?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vanhoozen
Dr. Brent Vanhoozen is a critical care medicine specialist in Roseville, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Vanhoozen performed 2,089 Medicare services across 1,585 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vanhoozen received a total of $9,680 from 50 pharmaceutical and/or device companies across 444 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vanhoozen is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 15% volume in CA
$9,680 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,089
Medicare services
Top 15% in CA for critical care medicine
1,585
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~110 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
394 | $174 | $665 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
285 | $64 | $225 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
283 | $7 | $30 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
281 | $10 | $40 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
273 | $96 | $300 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
169 | $8 | $45 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
133 | $7 | $25 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
81 | $73 | $200 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
50 | $144 | $585 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
47 | $103 | $300 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
24 | $92 | $303 |
| Additional 30 minutes of critical care This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period. |
21 | $88 | $330 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
18 | $132 | $465 |
| Bronchoscopy A diagnostic exam of the lung airways using an endoscope to visually inspect the inside of the lungs and airways. |
17 | $107 | $444 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
13 | $88 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,680
Total received (2018-2024)
Avg $1,383/year across 7 years
Top 14% in CA for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
444
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,619 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$61 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,644
2023
$1,311
2022
$1,168
2021
$1,263
2020
$1,155
2019
$1,561
2018
$1,578
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$395
ABBVIE INC.
$369
Astellas Pharma US Inc
$200
ViiV Healthcare Company
$191
Boehringer Ingelheim Pharmaceuticals, Inc.
$82
GlaxoSmithKline, LLC.
$75
Amgen Inc.
$69
United Therapeutics Corporation
$48
Baxter Healthcare
$42
Inari Medical, Inc.
$37
GENZYME CORPORATION
$30
Gilead Sciences, Inc.
$24
Pulmonx Corporation
$24
Philips North America LLC
$15
PFIZER INC.
$15
Grifols USA, LLC
$15
Electromed, Inc.
$15
Top 3 companies account for 58.6% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,262
AbbVie Inc.
$966
ABBVIE INC.
$879
Allergan Inc.
$873
Boehringer Ingelheim Pharmaceuticals, Inc.
$701
AstraZeneca Pharmaceuticals LP
$641
Astellas Pharma US Inc
$549
ViiV Healthcare Company
$400
Allergan, Inc.
$343
Novo Nordisk Inc
$287
Inari Medical, Inc.
$218
United Therapeutics Corporation
$199
Gilead Sciences, Inc.
$176
Genentech USA, Inc.
$171
PORTOLA PHARMACEUTICALS, INC.
$168
Intuitive Surgical, Inc.
$153
Sunovion Pharmaceuticals Inc.
$136
Merck Sharp & Dohme Corporation
$131
Amgen Inc.
$130
Shire North American Group Inc
$115
Philips Electronics North America Corporation
$112
Grifols USA, LLC
$109
Electromed, Inc.
$90
Baxter Healthcare
$75
Regeneron Healthcare Solutions, Inc.
$68
Advanced Respiratory, Inc
$65
Takeda Pharmaceuticals U.S.A., Inc.
$64
Resmed Corp
$60
Harmony Biosciences LLC
$50
Janssen Biotech, Inc.
$48
Mylan Specialty L.P.
$36
Pulmonx Corporation
$35
Theratechnologies Inc.
$35
Covis Pharma GmBH
$30
GENZYME CORPORATION
$30
Insmed, Inc.
$29
Merck Sharp & Dohme LLC
$26
SANOFI-AVENTIS U.S. LLC
$24
ADVANCED RESPIRATORY, INC
$23
Horizon Pharma plc
$19
Greer Laboratories, Inc.
$19
Shionogi Inc
$18
La Jolla Pharmaceutical Company
$18
Bayer HealthCare Pharmaceuticals Inc.
$17
Philips North America LLC
$15
PFIZER INC.
$15
EMD Serono, Inc.
$14
Bio Products Laboratory USA, Inc.
$14
HARTMANN USA, INC.
$13
Janssen Pharmaceuticals, Inc
$11
Top 3 companies account for 32.1% of all-time payments
Associated products mentioned in payments ›
(8275) DreamStation Cpap Auto · (8874) inCourage · (AK6) Vest Therapy · ACTIMMUNE · AIRSUPRA · ALVESCO · AMBISOME · ANDEXXA · ANORO · ANORO ELLIPTA · AVYCAZ · Adempas · AirSense · AmBisome · Arikayce · BEVESPI AEROSPHERE · BEVYXXA · BREO · BREZTRI · CABENUVA · CHARTIS CATHETER · CRESEMBA · CT THROMBECTOMY SYSTEM KIT · CUVITRU · Cresemba · DALVANCE · DOVATO · DUPIXENT · Da Vinci Surgical System · EGRIFTA · ELIQUIS · Esbriet · FASENRA · FIRAZYR · FLOWTRIEVER CATHETER · Fetroja · GIAPREZA · GLASSIA · Gammaplex · Health&WellnessUndiv · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · ISENTRESS · LEXISCAN · LONHALA MAGNAIR · NUCALA · OFEV · ORALAIR · ORENITRAM · Ozempic · PIFELTRO · PREZCOBIX · Personal Care Undiv · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · RUKOBIA · Respiratoriy Care Undiv · S · SEROSTIM · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYMTUZA · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · Tavneos · The Vest System Model 105 Home Care · Tresiba · UBRELVY · Utibron · Wakix · XARELTO · Xultophy 100/3.6 · Yupelri · ZERBAXA · Zetuvit Plus
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Critical care medicines within 10 mi
45
Per 100K population
10.9
County median income
$114,678
Nearest hospital
SUTTER ROSEVILLE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Vanhoozen is a mixed practice specialist, with above-average Medicare volume (top 15% in CA), with low-engagement industry engagement in the top 14% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Vanhoozen experienced with critical care, first 30-74 min?
Based on Medicare claims data, Dr. Vanhoozen performed 394 critical care, first 30-74 min services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vanhoozen receive payments from pharmaceutical companies?
Yes. Dr. Vanhoozen received a total of $9,680 from 50 companies across 444 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vanhoozen's costs compare to other critical care medicines in Roseville?
Dr. Vanhoozen's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vanhoozen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Roseville
Browse critical care medicines in Roseville ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in CA
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in CA
Which CA critical care medicines receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology